Provided by Tiger Fintech (Singapore) Pte. Ltd.

Plus Therapeutics, Inc.

0.7900
-0.0527-6.25%
Volume:657.80K
Turnover:521.81K
Market Cap:13.43M
PE:-0.34
High:0.8203
Open:0.8203
Low:0.7721
Close:0.8427
Loading ...

BRIEF-Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins Its Board Of Directors

Reuters
·
23 Apr

Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins Its Board of Directors

THOMSON REUTERS
·
23 Apr

Press Release: Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins its Board of Directors

Dow Jones
·
23 Apr

Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases

GlobeNewswire
·
15 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Apr

Plus (PSTV) Upgraded to Buy: Here's What You Should Know

Zacks
·
02 Apr

Q4 2024 Plus Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
29 Mar

Plus Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
28 Mar

Plus Therapeutics Inc (PSTV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
28 Mar

Plus Therapeutics (PSTV) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
28 Mar

Plus Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Mar

Plus Therapeutics FY24 EPS $(1.95) Vs. $(4.24) YoY, Grant Revenue $5.8M Up From $4.9M YoY

Benzinga
·
28 Mar

BRIEF-Plus Therapeutics FY Net Income USD -12.978 Million

Reuters
·
28 Mar

Plus Therapeutics FY Operating Expenses USD 20.519 Million

THOMSON REUTERS
·
28 Mar

Plus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

GlobeNewswire
·
28 Mar

Why Plus Therapeutics Inc. (PSTV) Surged On Thursday?

Insider Monkey
·
21 Mar

Equity Markets Fall After Latest Unemployment Data

MT Newswires Live
·
21 Mar

Plus Therapeutics Shares Jump After FDA Accepts Name of Lead Tumor Treatment Candidate

MT Newswires Live
·
21 Mar

BUZZ-U.S. STOCKS ON THE MOVE-KKR, Micron Technology, Eli Lilly

Reuters
·
20 Mar

Plus Therapeutics announces FDA conditionally accepted name REYOBIQ

TIPRANKS
·
20 Mar